|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Molecular epidemiological studies suggest that particular Mycobacterium tuberculosis strains have an enhanced capacity to spread within a community. One strain, the Beijing genotype, has been associated with outbreaks in a number of communities throughout the world. IS6110 restriction fragment length polymorphism (RFLP) analysis was performed on M. tuberculosis isolates from 566 of the 721 patients (78.5%) diagnosed with tuberculosis (TB) on Gran Canaria Island from 1993 to 1996, as well as 35% of isolates from 1991-1992 (85 strains). RFLP identification of the family of strains of the Beijing genotype was confirmed by spoligotyping. Medical records of all patients were reviewed and epidemiological links were identified. Of 566 M. tuberculosis isolates from 1993 to 1996 with RFLP available, 72% belonged to clusters. The largest contained 75 cases and was caused by a strain of the Beijing genotype that was introduced to the island in 1993. It was found in 10 patients in 1993 (5.5%), 12 in 1994 (8.1%), 18 in 1995 (16.4%), and 35 in 1996 (27.1%). Epidemiological linkage was confirmed for 68% of cases. This study has demonstrated rapid dissemination of this strain of the Beijing genotype. This genotype might play an important role in the future of the worldwide tuberculosis epidemic.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: Beijing genotype; multidrug-resistant TB; RFLP; tuberculosis; W-family
The decline of tuberculosis (TB) in industrialized countries, which was accentuated by the introduction of effective treatment, was associated with a decline of interest in research on tuberculosis that left unanswered some fundamental questions concerning the transmission and spread of the disease. Renewed interest in the disease in the 1990s led to the development of new molecular techniques that can differentiate Mycobacterium tuberculosis strains, giving epidemiologists the tools to address some of these issues (1). For example, although it had been generally accepted that the majority of TB cases in low-incidence countries were the result of endogenous reactivations, a study from Denmark found that more than 50% of cases likely resulted from recent infections. Moreover, 40% of these recent transmissions were caused by only two M. tuberculosis strains (4).
The technique most commonly employed in the molecular epidemiology of tuberculosis is strain typing by restriction fragment length polymorphism (RFLP), a method based on the detection of differences in the numbers and locations of the insertion element IS6110 within the chromosomes of M. tuberculosis strains. However, this insertion element has a low but significant frequency of transposition, so that RFLP patterns show a certain amount of instability. The half-life of an IS6110 RFLP pattern has been estimated to be as short as 3 to 4 yr (5). In consequence, minor RFLP differences in the offspring of a parental strain may complicate or confuse long-term studies of molecular epidemiology.
A newer technique, spoligotyping, is based on the detection of the different DNA spacer sequences that lie between direct repeats (DRs) in the M. tuberculosis chromosome (6). The composition of the DR region appears to be a more stable characteristic of a particular strain than the IS6110-associated RFLP (7). In a previous study, spoligotyping was shown to be reliable in identifying strains that were highly similar in their IS6110 RFLPs (8).
Spoligotyping has demonstrated that one strain family of M. tuberculosis is predominant in the Beijing area of China and is common throughout Asia (8) and the western pacific region (9). This strain has been termed the "Beijing" genotype. Spoligotyping also demonstrated that the multidrug- resistant (MDR) "W" strain, which caused tuberculosis in more than 350 patients in New York City and accounted for more than 25% of all MDR TB cases in the United States in the 1990s, is a member of the strain family of the Beijing genotype (10). The Beijing genotype has been documented to be associated with the transmission of drug-resistant tuberculosis in Germany, Russia, Estonia, South Africa, and Colombia (11). In addition, two studies in Vietnam found the Beijing genotype to be significantly associated with younger age of patients, evidence suggesting that it is emerging as an important component of the tuberculosis transmission pattern in that country (11, 15).
The present study describes the introduction of a strain of the Beijing genotype into the population of Gran Canaria Island by an African refugee in 1993, and its explosive spread in this community over the subsequent few years. To our knowledge, this is the first documentation of the introduction and spread of a highly virulent M. tuberculosis strain into a community where all the cases have been systematically evaluated with molecular techniques.
| |
METHODS |
|---|
|
|
|---|
The Canary Islands (Spain) are located in the Atlantic Ocean, close to the North African coast. The most populated island is Gran Canaria, which has 713,768 inhabitants, more than half of whom live in the city of Las Palmas. The island has good health care services, and all inhabitants, including immigrants and homeless persons, have access to free health care. Gran Canaria Island has a well-organized tuberculosis control program (14) and a TB notification rate per 100,000 inhabitants of 32.2 in 1988, 28.5 in 1993, 29.0 in 1996, and 29.3 in 1999 (16). Acid-fast smears and mycobacterial cultures are routinely requested from all patients with respiratory symptoms.
The study population included 566 of the 721 patients (78.5%) diagnosed with tuberculosis on Gran Canaria Island from January 1, 1993 to December 31, 1996 who had bacteriologic confirmation by culture. In addition, 85 (74 living in Las Palmas City) of 244 patients (35%) during the period 1991-1992, from whom cultures were available, and all patients with cultures from which M. tuberculosis was isolated during the last 3 mo of 1999 (40 patients) were evaluated. Medical records were reviewed to obtain demographic data, tuberculosis risk factors, and clinical characteristics of the illness. Epidemiological links were identified. The human immunodeficiency virus (HIV) test was performed on all patients with tuberculosis, accompanied by pre- and posttest counseling. All results of medical examinations were kept in strict confidence.
All patients received a standard 6-mo treatment with isoniazid (H), rifampin (R), and pyrazinamide for the initial 2 mo, and then with H and R for the remaining 4 mo (17).
The M. tuberculosis strains were stored in a
40° C freezer in liquid Dubos medium and subcultured on Löwenstein-Jensen medium. One isolate from each patient was typed by the internationally standardized method of restriction fragment length polymorphism (RFLP),
using insertion sequence IS6110 as a probe (1). A cluster of M. tuberculosis isolates was defined as two or more isolates with identical
RFLP patterns consisting of five or more bands. To ensure that clustered isolates were not the result of laboratory cross-contamination,
patients with a single positive culture but negative acid-fast smears
were considered to be false positives if their sputum samples were
processed in a laboratory on the same day as a positive smear from
another patient with the same RFLP pattern.
After RFLP pattern analysis, all patient included in clusters were
further studied by conventional contact tracing
clinical records and
personal interview of all the patients
for evidence of epidemiological linkage. Epidemiological linkage was considered to be present
when two patients belonged to the same population in a small area.
Spoligotyping was used to confirm that strains belonged to the Beijing genotype. Spoligotyping characterizes the polymorphic direct repeat (DR) region of the M. tuberculosis chromosome (6). The Beijing genotype is defined as strains containing only the last 9 of the 43 possible spacers (8).
RFLP and spoligotyping patterns were subjected to computer- assisted analysis using GelCompar 4.1 (Applied Maths, Kortrijk, Belgium). The results were compared with an extensive database containing the RFLP and spoligotyping patterns of thousands of strains isolated in diverse geographical locations maintained at the National Institute of Public Health and Environmental Protection (RIVM) in The Netherlands and with the database of Spanish strains maintained at the University of Zaragoza (Zaragoza, Spain), including MDR TB strains (18). The value of 75% was specified for minimum correlation and Dice coefficient as similar coefficient for identification of the Beijing genotype because all strains known to belong to the Beijing family of strains are included in this percentage of similarity in our databases.
For statistical analysis,
2 and Fisher exact tests were used to analyze for linear trend. A p value of < 0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Five hundred and sixty-six of the 721 M. tuberculosis isolates (78.5%) from the period 1993-1996 were typed by RFLP typing and 409 (72.3%) were found to belong to 1 of 78 clusters containing at least 2 identical strains. The largest cluster (Cluster 1) consisted of 75 isolates with an identical IS6110 RFLP pattern of 15 bands. From 1991 to 1996, an increasing percentage of isolates belonged to Cluster 1 (Table 1, p < 0.001 for trend in proportions). This RFLP pattern was not found in any of the 85 M. tuberculosis strains isolated in the period from 1991 to 1992, suggesting that the strain entered the island in 1993.
|
Among the 75 cases in Cluster 1, the median age was 35.0 ± 14.8 yr (range, 3-81 yr). Epidemiological linkage was confirmed for 51 (68%) of the cases in this cluster: 29 (39%) were intravenous drug users, 26 (35%) were HIV positive, 14 (19%) were immigrants (4 from sub-Saharan West African countries, all of them living in the same block), 12 (16%) had spent time in prison, and 9 (12%) were homeless. The median age of all TB cases was 39.9 ± 17.6 yr (range, 1-87 yr), and 13% were intravenous drug users, 15% were HIV positive, 7% were immigrants, 7% had spent time in prison, and 6% were homeless. Figure 1 illustrates the geographic proximity of the clustered cases.
|
The first case with the strain of Cluster 1 recognized on the island (the apparent index case) was a refugee from Liberia diagnosed with smear-positive pulmonary tuberculosis, with a smear grading of 4+ and laryngeal tuberculosis that had not been diagnosed in July 1993, 6 mo after his arrival on the island. He was an intravenous drug user (IVDU), and HIV negative. He was enrolled in a program with directly observed therapy (17), but because of frequent changes in his domicile he failed to take the prescribed medications on a regular basis and his treatment had to be extended over a prolonged period. The patient's tuberculosis had not been cured when the public health system of the island lost contact with him at the end of 1996. The last M. tuberculosis isolate taken from this patient, in August 1995, was still susceptible to all drugs tested. The patient initially lived with other homeless persons on an old ship in the Las Palmas harbor. The index case had contact with 14 members of 5 communities. Many of the other patients belonging to Cluster 1 (20%) also lived in this part of the city (Port-La Isleta), which is a nexus for illegal drug sales, illegal immigrants, and the homeless. Four patients from this community transmitted TB to another three communities. The entry and prolific spread of this genotype M. tuberculosis strain in the island is shown in Figure 2.
|
The RFLP pattern of Cluster 1 was found to be at least 75% identical to the RFLPs of 943 previously identified Beijing genotype strains from 24 different geographic areas, including Beijing, Mongolia, and Vietnam, documented in the RIVM (Figure 3). The database contained four strains, identical to Cluster 1, that were isolated in Africa, one each, in Somalia, Ethiopia, Sierra Leone and Liberia (Figure 4). The 75 strains isolated in Cluster 1 were also analyzed by spoligotyping, and all hybridized to oligonucleotides representing spacers 35 to 43, which is characteristic of the family of strains of the Beijing genotype. Spoligotyping was performed on all 40 M. tuberculosis strains isolated on Gran Canaria Island during the last 3 mo of 1999. Nine of these 40 isolates (22.5%) were found to have the Beijing genotype, suggesting an association with Cluster 1.
|
|
Initial isolates from all Cluster 1 patients were susceptible to all antibiotics tested. Of these 75 patients, 72 were cured by a standard 6-mo treatment protocol. In two cases, multidrug-resistant strains were subsequently isolated. One of these was HIV positive, alcoholic, and used intravenous drugs, whose tuberculosis was diagnosed in December 1994. After the patient had defaulted from treatment several times, an H and R-resistant strain was isolated from her sputum. She was subsequently hospitalized for 5 mo of treatment with second-line drugs, and in 1999 her sputum was negative by direct examination and culture. The other patient, who was diagnosed in September 1995, also adhered poorly to the treatment regimen, and has remained culture positive with a strain resistant to H and R since December 1997. These patients were two of the four cases, from the whole of Spain in 1998, with a strain of the Beijing genotype registered in the database at the University of Zaragoza.
| |
DISCUSSION |
|---|
|
|
|---|
Molecular epidemiology is a valuable tool in studying the transmission of tuberculosis. It can verify transmission patterns suspected from traditional epidemiologic investigation, reveal unexpected transmission routes, and, as demonstrated here, identify the contribution of highly transmissible M. tuberculosis strains. This report has documented that a strain of the Beijing genotype, not previously identified on Gran Canaria Island, spread over a period of only 4 yr to become the most common isolate on the island. Since its introduction in 1993, this strain has had a considerable impact on the TB incidence on Gran Canaria Island, causing a small increase in the notification rates in the 1993-1996 period in a well-organized tuberculosis control program (16). More than one in eight of all tuberculosis cases diagnosed between 1993 and 1996, and more than one in five cases in late 1999, were caused by this strain. This cluster of 75 patients is one of the largest recorded clusters, comparable to one described in Greenland (19). The emergence of another strain of the Beijing genotype has been reported in Vietnam (11, 15) and Iran (20), where it was isolated from a high percentage of young tuberculosis patients (11). Less than 4% of MDR strains systematically typed in the database at the University of Zaragoza were found to belong to the Beijing genotype when spoligotyping was performed.
The international Gel Compare database, including thousands of RFLP patterns of M. tuberculosis strains, has demonstrated that the Beijing genotype has a worldwide distribution. The Cluster 1 strain of the Beijing genotype apparently entered Gran Canaria Island with an African refugee. Only four strains identical to those of Cluster 1 have been identified in the international Gel Compare database, one each in Somalia, Ethiopia, Sierra Leone, and Liberia. The latter was the country of origin of the African refugee in this study. The Cluster 1 strain rapidly spread to close contacts in his community, which contained individuals with the high-risk characteristics described in several other TB outbreaks (21). Its extensive spread might be explained by a high degree of susceptibility and close contact among the population into which it was introduced and may be due to the exceptional virulence of this strain (24). The key role of prolonged exposure due to poor adherence to treatment, loss to follow-up without documented cure, and the development of multidrug resistance in some individuals in the cluster must also be taken into account. Nonetheless, other strains isolated from members of the same community have not demonstrated the pattern of rapid spread seen with the Cluster 1 strain (17).
Reports documenting the Beijing genotype in predominant, highly transmissible strains found in distinct geographic locations support the idea that it is more virulent than other strains of M. tuberculosis. Chance would predict that a few strains would eventually emerge as predominant in any given population, but this cannot explain how a single genotype has become predominant in many different, geographically separate populations, and implies that the Beijing genotype has some advantage over other strains in its ability to be transmitted and cause disease (25). A previous report (26) from the same community has demonstrated the higher frequency of the same Beijing genotype of the Cluster 1 strain among recurrent cases caused by reinfection than among those resulting from reactivation of the initial strain. These results might suggest a higher level of virulence of the strain demonstrated by its ability to reinfect patients who had been previously cured of disease caused by other strains.
Previous studies have reported a significant correlation between the Beijing genotype and drug resistance (9, 27). Perhaps the virulence of this strain is related to an exceptional capacity to replicate within the patient, and the greater bacterial load increasing the odds for selecting a drug-resistant mutant. The present study was unable to confirm the relation between this strain of the Beijing genotype and the development of drug resistance, as poor adherence to therapy was so obviously a key factor in those cases that developed multidrug resistance.
The outbreak reported here, on an island in Western Europe with a moderate notification rate of tuberculosis, together with other reports from Asia and the former Soviet Union, suggest that this strain could be responsible for an important component of the worldwide resurgence of tuberculosis, and may represent an epidemic within the larger tuberculosis epidemic. A key priority in tuberculosis research is the development of an effective vaccine (28). The integration of work on the molecular epidemiology, immunology, and molecular genetics of tuberculosis, with an emphasis on study strains of differing virulence, might help in the development of a more effective vaccine.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to José A. Caminero, MD, Service of Pneumology, University General Hospital Dr. Negrín, Barranco de la Ballena s/n, 35020 Las Palmas de Gran Canaria, Spain. E-mail: jcaminer{at}separ.es
(Received in original form January 8, 2001 and accepted in revised form July 2, 2001).
Acknowledgments: The authors thank Juan R. Verona and Ramon Saavedra, Illustration Unit of University General Hospital "Dr. Negrin" (Las Palmas de Gran Canaria, Spain), for secretarial and graphics assistance, and Angeles Figuerola, of the Preventive Medicine Service, for assistance in the statistical analysis.
Supported by Fondo de Investigación Sanitaria (grants 96/0676 and 00/1170), Ministerio de Sanidad y Consumo, Spain. Laboratories 5, 6, and 7 are members of RELACTB (Red Latinoamericana y del Caribe de Tuberculosis), University of the United Nations.
| |
References |
|---|
|
|
|---|
1.
van Embden JD,
Cave MD,
Crawford JT,
Dale JW,
Eisenach KD,
Gicquel B,
Hermans P,
Martin C,
McAdam R,
Shinnick TM.
Strain identification
of Mycobacterium tuberculosis by DNA fingerprinting: recommendations
for a standardized methodology.
J Clin Microbiol
1993;
31:
406-409
2.
Kremer K,
van Soolingen D,
Frothingham R,
Haas WH,
Hermans PW,
Martin C,
Palittapongarnpim P,
Plikaytis BB,
Riley LW,
Yakrus MA, et al
.
Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex
strains: interlaboratory study of discriminatory power and reproducibility.
J Clin Microbiol
1999;
37:
2607-2618
3.
van Rie A,
Warren R,
Richardson M,
Victor TC,
Gie RP,
Enarson DA,
Beyers N,
van Helden PD.
Exogenous reinfection as a cause of recurrent
tuberculosis after curative treatment.
N Engl J Med
1999;
341:
1174-1179
4.
Bauer J,
Yang Z,
Poulsen S,
Andersen AB.
Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex
isolates in a country with a low incidence of M. tuberculosis infection.
J Clin Microbiol
1998;
36:
305-308
5. de Boer AS, Borgdorff MW, de Haas PE, Nagelkerke NJ, van Embden JD, van Soolingen D. Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates. J Infect Dis 1999; 180: 1238-1244 [Medline].
6.
Kamerbeek J,
Schouls L,
Kolk A,
van Agterveld M,
van Soolingen D,
Kuijper S,
Bunschoten A,
Molhuizen H,
Shaw R,
Goyal M, et al
.
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis
for diagnosis and epidemiology.
J Clin Microbiol
1997;
35:
907-914
7.
Alito A,
Morcillo N,
Scipioni S,
Dolmann A,
Romano MI,
Cataldi A,
van Soolingen D.
The IS6110 restriction fragment length polymorphism in particular multidrug-resistant Mycobacterium tuberculosis
strains may evolve too fast for reliable use in outbreak investigation.
J Clin Microbiol
1999;
37:
788-791
8.
van Soolingen D,
Qian L,
de Haas PE,
Douglas JT,
Traore H,
Portaels F,
Qing HZ,
Enksaikan D,
Nymadawa P,
van Embden JC.
Predominance of a single genotype of Mycobacterium tuberculosis in countries
of East Asia.
J Clin Microbiol
1995;
33:
3234-3238
9.
Park YK,
Bai GH,
Kim SJ.
Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in western Pacific region.
J Clin Microbiol
2000;
38:
191-197
10.
Bifani PJ,
Plikaytis BB,
Kapur V,
Stockbauer K,
Pan X,
Lutfey ML,
Moghazeh SL,
Eisner W,
Daniel TM,
Kaplan MH, et al
.
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family.
JAMA
1996;
275:
452-457
11. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K, van Soolingen D. The Mycobacterium tuberculosis "Beijing" genotype is emerging in Vietnam. Emerg Infect Dis 2000;6:362-365.
12. Portaels F, Rigouts L, Bastian I. Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union. Int J Tuberc Lung Dis 1999; 3: 582-588 [Medline].
13. van Rie A, Warren RM, Beyers N, Gie RP, Classen CN, Richardson M, Sampson SL, Victor TC, van Helden PD. Transmission of a multidrug- resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis 1999; 180: 1608-1615 [Medline].
14. Laserson KF, Osorio L, Sheppard JD, Hernandez H, Benitez AM, Brim S, et al . Clinical and programmatic mismanagement rather than community outbreak as the cause of chronic, drug-resistant tuberculosis in Buenaventura, Colombia, 1998. Int J Tuberc Lung Dis 2000; 4: 673-683 [Medline].
15. Le TK, Bach KH, Ho ML, Le NV, Nguyen TM, Chevrier D, et al. Molecular fingerprinting of Mycobacterium tuberculosis strains isolated in Vietnam using IS6110 as probe. Tuberc Lung Dis 2000;80:75-83.
16. Caminero JA, Díaz F, Rodríguez de Castro F, Pavón JM, Esparza R, Cabrera P. The epidemiology of tuberculosis in Gran Canaria, Canary Islands, 1988-92: effectiveness of control measures. Tuberc Lung Dis 1995; 76: 387-393 [Medline].
17.
Caminero JA,
Pavón JM,
Rodríguez de Castro F,
Diaz F,
Julia G,
Cayla JA,
Cabrera P.
Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of
poor compliance.
Thorax
1996;
51:
1130-1133
18. Samper S, Iglesias MJ, Tello O. The Spanish Multidrug Resistant Tuberculosis Network. Eurosurveillance 2000; 5: 43-45 .
19.
Yang ZH,
de Haas PE,
van Soolingen D,
van Embden JD,
Andersen AB.
Restriction fragment length polymorphism Mycobacterium tuberculosis strains isolated from Greenland during 1992: evidence of tuberculosis transmission between Greenland and Denmark.
J Clin Microbiol
1994;
32:
3018-3025
20. Doroudchi M, Kremer K, Basiri EA, Kadivar MR, Van Soolingen D, Ghaderi AA. IS6110 and spoligotyping of Mycobacterium tuberculosis isolates in Iran. Scand J Infect Dis 2000; 32: 663-668 [Medline].
21.
Small PM,
Hopewell PC,
Singh SP,
Paz A,
Parsonnet J,
Ruston DC,
Schecter GF,
Daley CL,
Schoolnik GK.
The epidemiology of tuberculosis in San Francisco: a population-based study using conventional
and molecular methods.
N Engl J Med
1994;
330:
1703-1709
22.
Frieden TR,
Sterling T,
Pablos-Mendez A,
Kilburn JO,
Cauthen GM,
Dooley SW.
The emergence of drug-resistant tuberculosis in New
York City.
N Engl J Med
1993;
328:
521-526
23.
Alland D,
Kakut GE,
Moss AR,
McAdam RA,
Hahn JA,
Bosworth W,
Drucker E,
Bloom BR.
Transmission of tuberculosis in New York city:
analysis by DNA fingerprinting and conventional epidemiological methods.
N Engl J Med
1994;
330:
1710-1716
24.
Valway SE,
Sanchez MP,
Shinnick TF,
Orme I,
Agerton T,
Hoy D,
Jones JS,
Westmareland H,
Onorato IM.
An outbreak involving extensive transmission of a virulent strain of
Mycobacterium tuberculosis. N Engl J Med
1998;
338:
633-639
.
25. Anderson RM, May RM. Parasites, genetic variability and drug resistance. In: Infectious diseases of humans, dynamics, and control. Oxford: Oxford Science Publications; 1991. p. 607-625.
26.
Caminero J,
Pena MJ,
Campos-Herrero MI,
Rodriguez JC,
Afonso O,
Martin C,
Pavon JM,
Torres MJ,
Burgos M,
Cabrera P, et al
.
Exogenous reinfection of tuberculosis on a European island with a moderate
incidence of disease.
Am J Respir Crit Care Med
2001;
163:
717-720
27. Codina G, Vidal R, Martín-Casabona N, Miravitlles M, Martín C. Multidrug-resistant tuberculosis caused by "W"-related strains in three immunocompetent foreign born patients. Int J Tuberc Lung Dis 1999; 3: 82-83 [Medline].
28. Orme IM. New vaccines against tuberculosis. The status of current research. Infect Dis Clin North Am 1999;13:169-185, vii-viii.
This article has been cited by other articles:
![]() |
G. Huet, P. Constant, W. Malaga, M.-A. Laneelle, K. Kremer, D. van Soolingen, M. Daffe, and C. Guilhot A Lipid Profile Typifies the Beijing Strains of Mycobacterium tuberculosis: IDENTIFICATION OF A MUTATION RESPONSIBLE FOR A MODIFICATION OF THE STRUCTURES OF PHTHIOCEROL DIMYCOCEROSATES AND PHENOLIC GLYCOLIPIDS J. Biol. Chem., October 2, 2009; 284(40): 27101 - 27113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Borrell, M. Espanol, A. Orcau, G. Tudo, F. March, J. A. Cayla, J. M. Jansa, F. Alcaide, N. Martin-Casabona, M. Salvado, et al. Factors Associated with Differences between Conventional Contact Tracing and Molecular Epidemiology in Study of Tuberculosis Transmission and Analysis in the City of Barcelona, Spain J. Clin. Microbiol., January 1, 2009; 47(1): 198 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mokrousov, O. Narvskaya, A. Vyazovaya, J. Millet, T. Otten, B. Vishnevsky, and N. Rastogi Mycobacterium tuberculosis Beijing Genotype in Russia: in Search of Informative Variable-Number Tandem-Repeat Loci J. Clin. Microbiol., November 1, 2008; 46(11): 3576 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caws, G. Thwaites, K. Stepniewska, N. T. N. Lan, N. T. H. Duyen, N. T. Phuong, M. N. T. Huyen, P. M. Duy, T. H. Loc, T. T. H. Chau, et al. Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with Human Immunodeficiency Virus Infection and Multidrug Resistance in Cases of Tuberculous Meningitis J. Clin. Microbiol., November 1, 2006; 44(11): 3934 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mokrousov, W. W. Jiao, V. Valcheva, A. Vyazovaya, T. Otten, H. M. Ly, N. N. Lan, E. Limeschenko, N. Markova, B. Vyshnevskiy, et al. Rapid Detection of the Mycobacterium tuberculosis Beijing Genotype and Its Ancient and Modern Sublineages by IS6110-Based Inverse PCR J. Clin. Microbiol., August 1, 2006; 44(8): 2851 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hasan, M. Tanveer, A. Kanji, Q. Hasan, S. Ghebremichael, and R. Hasan Spoligotyping of Mycobacterium tuberculosis Isolates from Pakistan Reveals Predominance of Central Asian Strain 1 and Beijing Isolates J. Clin. Microbiol., May 1, 2006; 44(5): 1763 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Filliol, A. S. Motiwala, M. Cavatore, W. Qi, M. H. Hazbon, M. Bobadilla del Valle, J. Fyfe, L. Garcia-Garcia, N. Rastogi, C. Sola, et al. Global Phylogeny of Mycobacterium tuberculosis Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set J. Bacteriol., January 15, 2006; 188(2): 759 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Rao, N. Ahmed, S. Srinivas, L. A. Sechi, and S. E. Hasnain Rapid Identification of Mycobacterium tuberculosis Beijing Genotypes on the Basis of the Mycobacterial Interspersed Repetitive Unit Locus 26 Signature J. Clin. Microbiol., January 1, 2006; 44(1): 274 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Freeman, M. Kato-Maeda, K. A. Hauge, K. L. Horan, E. Oren, M. Narita, C. K. Wallis, D. Cave, C. M. Nolan, P. M. Small, et al. Use of Rapid Genomic Deletion Typing To Monitor a Tuberculosis Outbreak within an Urban Homeless Population J. Clin. Microbiol., November 1, 2005; 43(11): 5550 - 5554. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. van Deutekom, P. Supply, P. E. W. de Haas, E. Willery, S. P. Hoijng, C. Locht, R. A. Coutinho, and D. van Soolingen Molecular Typing of Mycobacterium tuberculosis by Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Analysis, a More Accurate Method for Identifying Epidemiological Links between Patients with Tuberculosis J. Clin. Microbiol., September 1, 2005; 43(9): 4473 - 4479. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Drobniewski, Y. Balabanova, V. Nikolayevsky, M. Ruddy, S. Kuznetzov, S. Zakharova, A. Melentyev, and I. Fedorin Drug-Resistant Tuberculosis, Clinical Virulence, and the Dominance of the Beijing Strain Family in Russia JAMA, June 8, 2005; 293(22): 2726 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Samper, M. J. Iglesias, M. J. Rabanaque, L. I. Gomez, M. C. Lafoz, M. S. Jimenez, A. Ortega, M. A Lezcano, D. Van Soolingen, C. Martin, et al. Systematic Molecular Characterization of Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates from Spain J. Clin. Microbiol., March 1, 2005; 43(3): 1220 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jou, C.-Y. Chiang, and W.-L. Huang Distribution of the Beijing Family Genotypes of Mycobacterium tuberculosis in Taiwan J. Clin. Microbiol., January 1, 2005; 43(1): 95 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aranaz, B. Romero, N. Montero, J. Alvarez, J. Bezos, L. de Juan, A. Mateos, and L. Dominguez Spoligotyping Profile Change Caused by Deletion of a Direct Variable Repeat in a Mycobacterium tuberculosis Isogenic Laboratory Strain J. Clin. Microbiol., November 1, 2004; 42(11): 5388 - 5391. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. van Deutekom, S. P. Hoijng, P. E. W. de Haas, M. W. Langendam, A. Horsman, D. van Soolingen, and R. A. Coutinho Clustered Tuberculosis Cases: Do They Represent Recent Transmission and Can They Be Detected Earlier? Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 806 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Milan, K. A. Hauge, N. E. Kurepina, K. H. Lofy, S. V. Goldberg, M. Narita, C. M. Nolan, P. D. McElroy, B. N. Kreiswirth, and G. A. Cangelosi Expanded Geographical Distribution of the N Family of Mycobacterium tuberculosis Strains within the United States J. Clin. Microbiol., March 1, 2004; 42(3): 1064 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Barnes and M. D. Cave Molecular Epidemiology of Tuberculosis N. Engl. J. Med., September 18, 2003; 349(12): 1149 - 1156. [Full Text] [PDF] |
||||
![]() |
M J Pena, J A Caminero, M I Campos-Herrero, J C Rodriguez-Gallego, M I Garcia-Laorden, P Cabrera, M J Torres, B Lafarga, F Rodriguez de Castro, S Samper, et al. Epidemiology of tuberculosis on Gran Canaria: a 4 year population study using traditional and molecular approaches Thorax, July 1, 2003; 58(7): 618 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Filliol, J. R. Driscoll, D. van Soolingen, B. N. Kreiswirth, K. Kremer, G. Valetudie, D. D. Anh, R. Barlow, D. Banerjee, P. J. Bifani, et al. Snapshot of Moving and Expanding Clones of Mycobacterium tuberculosis and Their Global Distribution Assessed by Spoligotyping in an International Study J. Clin. Microbiol., May 1, 2003; 41(5): 1963 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Werngren and S. E. Hoffner Drug-Susceptible Mycobacterium tuberculosis Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated Rate J. Clin. Microbiol., April 1, 2003; 41(4): 1520 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Puustinen, M. Marjamaki, N. Rastogi, C. Sola, I. Filliol, P. Ruutu, P. Holmstrom, M. K. Viljanen, and H. Soini Characterization of Finnish Mycobacterium tuberculosis Isolates by Spoligotyping J. Clin. Microbiol., April 1, 2003; 41(4): 1525 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Tobin Compliance (COMmunicate PLease wIth Less Abbreviations, Noun Clusters, and Exclusiveness) Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): 1534 - 1536. [Full Text] [PDF] |
||||
![]() |
S. E. Weis, J. M. Pogoda, Z. Yang, M. D. Cave, C. Wallace, M. Kelley, and P. F. Barnes Transmission Dynamics of Tuberculosis in Tarrant County, Texas Am. J. Respir. Crit. Care Med., July 1, 2002; 166(1): 36 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.V. Burgos and A.S. Pym Molecular epidemiology of tuberculosis Eur. Respir. J., July 1, 2002; 20(36_suppl): 54S - 65s. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Loddenkemper, D. Sagebiel, and A. Brendel Strategies against multidrug-resistant tuberculosis Eur. Respir. J., July 1, 2002; 20(36_suppl): 66S - 77s. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Toungoussova, P. Sandven, A. O. Mariandyshev, N. I. Nizovtseva, G. Bjune, and D. A. Caugant Spread of Drug-Resistant Mycobacterium tuberculosis Strains of the Beijing Genotype in the Archangel Oblast, Russia J. Clin. Microbiol., June 1, 2002; 40(6): 1930 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Tuberculosis, Lung Infections, Interstitial Lung Disease, and Socioeconomic Issues in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 631 - 641. [Full Text] [PDF] |
||||
![]() |
W. Bishai Tuberculosis Transmission-Rogue Pathogen or Rogue Patient? Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1104 - 1105. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |